Valganciclovir in Infants with Hearing Loss and Clinically Inapparent Congenital Cytomegalovirus Infection: A Nonrandomized Controlled Trial

To assess the efficacy of valganciclovir in infants with hearing loss and clinically inapparent congenital cytomegalovirus infection (cCMV), as there is no consensus on treatment of this group.

Source: The Journal of Pediatrics - February 7, 2024 Category: Pediatrics Authors: Pui Khi Chung, Fleurtje A.J. Schornagel, Wim Soede, Erik W. van Zwet, Aloys C.M. Kroes, Anne Marie Oudesluys-Murphy, Ann C.T.M. Vossen Tags: Original Articles Source Type: research